[The intestinal microbiota composition in patients with multiple sclerosis receiving different disease-modifying therapies DMT].

Autor: Abdurasulova IN; Institute of Experimental Medicine, St-Petersburg, Russia; St-Petersburg State Pediatric Medical University, St-Petersburg, Russia., Tarasova EA; Institute of Experimental Medicine, St-Petersburg, Russia., Nikiforova IG; Bekhtereva Institute of the Human Brain, St-Petersburg., Il'ves AG; Bekhtereva Institute of the Human Brain, St-Petersburg., Ivashkova EV; Bekhtereva Institute of the Human Brain, St-Petersburg., Matsulevich AV; Institute of Experimental Medicine, St-Petersburg, Russia., Tatarinov AE; Institute of Experimental Medicine, St-Petersburg, Russia., Shangina LV; Institute of Experimental Medicine, St-Petersburg, Russia., Ermolenko EI; Institute of Experimental Medicine, St-Petersburg, Russia; St-Petersburg State University, St-Petersburg, Russia., Klimenko VM; Institute of Experimental Medicine, St-Petersburg, Russia., Stolyarov ID; Bekhtereva Institute of the Human Brain, St-Petersburg., Suvorov AN; Institute of Experimental Medicine, St-Petersburg, Russia; St-Petersburg State University, St-Petersburg, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2018; Vol. 118 (8. Vyp. 2), pp. 62-69.